Abstract

The International System for Reporting Serous Fluid Cytology (TIS) was recently developed. Given its novelty, most studies looking into the risk of malignancy (ROM) of serous effusion diagnostic categories were published before the development of TIS. We searched the database of our department for pleural effusions diagnosed in the last five years, excluding those without a corresponding pleural biopsy. Cases were reviewed and reclassified according to the TIS. A cytohistological correlation was performed. In total, 350 pleural effusion specimens with one or more corresponding pleural biopsies were included. After reclassification, 5 (1.43%) were nondiagnostic (ND), 253 (72.29%) were negative for malignancy (NFM), 7 (2.00%) had atypia of unknown significance (AUS), 14 (4.00%) were suspicious for malignancy (SFM), and 71 (20.57%) were malignant (MAL). Calculated ROM was 40% for ND, 20.16% for NFM, 42.86% for AUS, 78.57% for SFM, and 100% for MAL. Effusion cytology sensitivity and specificity were 60.29% and 98.56%, respectively. This is the first publication looking into the cytohistological correlation of a retrospective cohort of pleural effusions based on the TIS. We add to the body of data regarding the ROM for TIS categories, highlighting areas of potential future research.

Highlights

  • Between January 2016 and March 2021, a total of 1228 pleural effusion specimens were diagnosed in our department

  • We believe our numbers are too small to draw any significant conclusions in this regard. This is the first publication looking into the cytohistological correlation of a retrospective cohort of pleural effusions based on the recently published TIS

  • Our data show that effusion cytology is a sensitive and specific method for the diagnosis of malignancies of several types, in line with previous publications on the subject

Read more

Summary

Introduction

Effusion specimens are accessible with minimal complications, and examination of these specimens may yield important diagnostic information, as well as provide adequate material for ancillary diagnostic testing and the increasingly important molecular theranostic tests [1,2].

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call